Sumatriptan causes parallel decrease in plasma CGRP concentration and migraine headache during nitroglycerin-induced migraine attack [3]

Cephalalgia

Volumn 26, Issue 8, 2006, Pages 1037-1038

  Vanmolkot, F ^a   Van Der Schueren, B ^a   De Hoon, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GLYCERYL TRINITRATE; SEROTONIN RECEPTOR; SUMATRIPTAN; TRIPTAN DERIVATIVE;

BLOOD LEVEL; BRAIN BLOOD VESSEL; DRUG EFFICACY; HUMAN; LETTER; MIGRAINE; NERVE ENDING; PRESYNAPTIC INHIBITION; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; TRIGEMINAL NERVE;

BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE WITHOUT AURA; NITROGLYCERIN; SEVERITY OF ILLNESS INDEX; SUMATRIPTAN; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 33746055765     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01133_1.x     Document Type: Letter

References (11)

1. Arulmani U, Maassenvandenbrink A, Villalon CM, Saxena PR. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 2004; 500:315-30.
2. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28:183-7.
3. Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 1995; 15:384-90.
4. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000; 20:907-18.
5. Sarchielli P, Alberti A, Vaianella L, Pierguidi L, Floridi A, Mazzotta G et al. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks. Headache 2004; 44:961-8.
6. Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J et al. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 2003; 106:461-70.
7. Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 2005; 25:179-83.
8. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33:48-56.
9. Stepien A, Jagustyn P, Trafny EA, Widerkiewicz K. [Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks]. Neurol Neurochir Pol 2003; 37:1013-23.
10. Durham PL, Russo AF. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci 1999; 19:3423-9.
11. Arulmani U, Heiligers JP, Garrelds IM, Sanchez-Lopez A, Willems EW, Villalon CM et al. Effects of sumatriptan on capsaicin-induced carotid haemodynamic changes and CGRP release in anaesthetized pigs. Cephalalgia 2004; 24:717-27.